Media
Latest News
May 4, 2020
Gilead Sciences Inc. plans to spend $1 billion on its Covid-19 drug remdesivir. Now some members of Congress and health care watchdogs want to know how much consumers will pay.
Issues:Coronavirus (COVID-19)
May 3, 2020
President Donald Trump has been following up with the millions of Americans who received economic stimulus checks, touting the legislation that provided the financial relief and promising that America will prevail over an “invisible enemy.”
Issues:Coronavirus (COVID-19)
May 1, 2020
Washington, D.C. – Amid announcements concerning preliminary clinical trial data on remdesivir and anticipated emergency use authorization from the FDA, U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, and Rep. Rosa DeLauro (D-CT), Chair of the Labor, Health and Human Services, and Education Appropriations Subcommittee, urge Secretary Azar to release information about the extent of taxpayer investment in remdesivir, government ownership of any remdesivir patents, and any federal efforts to scale-up production. Arguing that an unaffordable drug is entirely ineffective for patients suffering, the members assert that “substantial taxpayer investments in COVID-19 pharmaceutical research must be recognized.”
Issues:Coronavirus (COVID-19)
May 1, 2020
An Austin-area veteran says Austin Community College sent him an email Thursday, telling him his GI Bill benefits were going to be slashed -- all because the school was listing summer school courses in a way that meant veterans wouldn't get the full housing benefit they earned. This comes as the school continues to offer online learning in response to the COVID-19 pandemic.
May 1, 2020
Now that preliminary trial results indicate an experimental Gilead Sciences (GILD) drug can successfully treat some Covid-19, one lawmaker wants to know if U.S. taxpayer dollars helped pay for any of the research and development and, if so, what the federal government will do to ensure that Americans do not later encounter “price gouging.”
Issues:Coronavirus (COVID-19)
April 30, 2020
Serological Testing Probe: Yesterday, House Ways and Means Health Subcommittee Chairman Lloyd Doggett (D-Texas) called on the FDA to "swiftly end" the "current ‘free-for-all' policy" on serological tests, demanding the agency "immediately require validation data" to help remove tests from the U.S.
April 29, 2020
Washington, D.C. – As the COVID-19 pandemic worsens and many states look to serologic testing in order to estimate the extent of COVID-19 infection, U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, led an effort to urge the Food and Drug Administration (FDA) to swiftly end the current “free-for-all” policy on serological tests, establish firm guidance for manufacturers, and remove tests from the market that do not meet reasonable specificity and sensitivity goals. He was joined in this request by Rep. Rosa DeLauro (D-CT), Chair of the Labor, Health and Human Services, and Education Appropriations Subcommittee.
Issues:Coronavirus (COVID-19)
April 28, 2020
Washington, D.C. – As more than 1.4 million Texans have filed for unemployment insurance amid the deepening economic crisis, and Texas Workforce Commission (TWC) struggles to handle the influx, U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, led all congressional Texas Democrats in urging Governor Abbott to help Texans experiencing ongoing delays in continuing their unemployment benefits by temporarily waiving the current biweekly recertification requirement. By relieving both unemployed Texans and the TWC of this requirement, Abbott could help far more people access needed aid faster.
Issues:Coronavirus (COVID-19)
April 25, 2020
Austin, Texas – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, responded to the Internal Revenue Service (IRS) requiring its employees who are answering phones, processing mail, and other “mission-critical work” to end telework and resume on-site duties in Austin, as soon as tomorrow, Sunday, without assuring that they will be provided personal protective equipment (PPE):
Issues:Coronavirus (COVID-19)
April 24, 2020
Washington, DC – Congressman Lloyd Doggett (D-TX) and Senator Sheldon Whitehouse (D-RI) unveiled bicameral legislation today to repeal a massive tax giveaway for a small group of wealthy taxpayers that Republicans included in the coronavirus relief bill. The legislation would do away with provisions in the Coronavirus Aid, Relief, and Economic Security (CARES) Act that the nonpartisan Joint Committee on Taxation (JCT) estimates will reduce government revenue by $160 billion over ten years, and that would overwhelmingly benefit wealthy taxpayers like hedge fund managers and real estate speculators.
Issues:Coronavirus (COVID-19)